Targeting the platelet-derived growth factor receptor α with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: Implications as a potential therapeutic target-Reference-Cited by-同舟云学术

Targeting the platelet-derived growth factor receptor α with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: Implications as a potential therapeutic target

Published:2005-03 Issue:3 Volume:4 Page:369-379
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Loizos Nick,Xu Yan,Huber Jim,Liu Meilin,Lu Dan,Finnerty Bridget,Rolser Robin,Malikzay Asra,Persaud Anita,Corcoran Erik,Deevi Dhanvanthri S.,Balderes Paul,Bassi Rajiv,Jimenez Xenia,Joynes Christopher J.,Mangalampalli Venkata R.M.,Steiner Philipp,Tonra James R.,Wu Yan,Pereira Daniel S.,Zhu Zhenping,Ludwig Dale L.,Hicklin Daniel J.,Bohlen Peter,Witte Larry,Kussie Paul

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer;Cancers;2024-03-28

2. Haploinsufficiency of Adenomatous Polyposis Coli Coupled with Kirsten Rat Sarcoma Viral Oncogene Homologue Activation and P53 Loss Provokes High-Grade Glioblastoma Formation in Mice;Cancers;2024-03-04

3. Randomized Phase 2 Clinical Trial of Olaratumab in Combination with Gemcitabine and Docetaxel in Advanced Soft Tissue Sarcomas;Cancers;2023-10-06

4. New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies;Biomedicine & Pharmacotherapy;2023-05

5. PDGFRα monoclonal antibody: Assessment of toxicity in juvenile mice administered a murine surrogate antibody of olaratumab;Birth Defects Research;2023-03-14